Internal Medicine Alert – September 30, 2016
September 30, 2016
View Issues
-
Influence of Sacubitril/Valsartan on 30-day Readmission After Heart Failure Hospitalization
Compared with enalapril, treatment with sacubitril/valsartan is more effective in reducing 30-day readmissions for any cause following discharge from congestive heart failure hospitalization.
-
Integrative Treatment for Restless Legs Syndrome: What Does the Evidence Say?
Medical evidence supports the use of physical activity and iron supplementation (for those with low serum ferritin) in patients presenting with restless legs syndrome.
-
The Zoster Vaccine Rapidly Loses Effectiveness in Adults Over 60
An observational study showed that while the shingles vaccine reduces the risk of herpes zoster, there is a major decline in effectiveness over just eight years in older adults.
-
Association of Traumatic Brain Injury with Late-life Neurodegenerative Diseases
Concern has been raised about an increased risk of Alzheimer’s disease, Parkinson’s disease, and other dementias following traumatic brain injury.
-
Oxycodone HCl and Naltrexone HCl Extended-release Capsules (Troxyca ER)
The combination oxycodone/naltrexone is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
-
Clinical Briefs
In this section: A game-changing blood pressure trial; new colorectal cancer screening recommendations; and predicting opioid abuse and dependence.